What is the CVSS score of CVE-2024-23620?

CVE-2024-23620 has a CVSS 3.1 base score of 7.8 (High). CVSS vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H. EPSS exploitation probability: 0.2%.

Merge Efilm Workstation CVE-2024-23620

HIGH

Improper Privilege Management (CWE-269)

2024-01-26 disclosures@exodusintel.com

Privilege Escalation IBM Merge Efilm Workstation

7.8

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

7.8 HIGH

AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Attack Vector

Local

Attack Complexity

Low

Privileges Required

Low

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

Jan 26, 2024 - 00:15 nvd

HIGH 7.8

DescriptionNVD

An improper privilege management vulnerability exists in IBM Merge Healthcare eFilm Workstation. A local, authenticated attacker can exploit this vulnerability to escalate privileges to SYSTEM.

AnalysisAI

An improper privilege management vulnerability exists in IBM Merge Healthcare eFilm Workstation. Rated high severity (CVSS 7.8), this vulnerability is low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified as Improper Privilege Management (CWE-269), which allows attackers to escalate privileges to gain unauthorized elevated access. An improper privilege management vulnerability exists in IBM Merge Healthcare eFilm Workstation. A local, authenticated attacker can exploit this vulnerability to escalate privileges to SYSTEM. Affected products include: Ibm Merge Efilm Workstation.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply principle of least privilege, validate privilege transitions, implement proper role separation.